Sir,
Cutaneous systemic sclerosis (scleroderma and CREST syndrome), and less frequently dermatomyositis and lupus, often show vascular abnormalities in hand nail fold capillaries. Capillaroscopy (an optical microscope with 5-1000 zoom power) has been used to diagnose these changes for over 30 years. 1 Handheld dermoscopes show magnified deep cutaneous structures using polarized light. As recently published by Mazzotti et al., 2 capillaroscopy and dermoscopy have shown good diagnostic correlation.
Our aim was to assess in a general setting if dermoscopy could be used in connective tissue diseases (CTD) as a tool to detect initial changes in nail folds, even in cases with negative autoimmune tests or undefined disorders. Twenty-five consecutive patients referred to our CTD dermatologic consultancy were tested with a handheld dermoscope in all 10 hand nail folds (nail fold dermoscopy was performed using an iPhone 4 (Apple Inc., Cupertino, CA, USA), Fotofinder software, and Handyscope (FotoFinder Systems GmbH, Bad Birnbach, Germany). In five patients, scleroderma pattern signs were detected (Figures 1 and 2), and were sent to a rheumatologist to perform a confirmation capillaroscopy. This approach made possible early diagnosis of two systemic sclerosis patients, later confirmed with immune-testing and follow-up.
Traditionally, capillaroscopy groups patients in terms of: 1 1. normal pattern (homogeneous aligned capillary plexus, with a mean linear density of 30 capillaries per 5 mm, with no morphological alterations); 2. non-specific scleroderma pattern; 3. scleroderma pattern, which includes two or more of the following: enlarged capillaries; hemorrhages (more than two punctuate hemorrhages per finger or confluent hemorrhage areas); disorganization of the normal capillary distribution; moderate or extensive capillary loss (i.e. avascular areas); and tortuous, crossed and/or ramified capillaries. 1, 3 Capillaroscopes are heavy and not widely used; in addition, the technique requires an apprenticeship. However, dermoscopy is commonplace for many dermatologists in pigmented lesions and inflammatory disorders. Signs detected by nail dermoscopy neither correlate with lung or esophagus involvement, nor anti-centromere/anti-topoisomerase-I antibodies. 3, 4 But as an example of dermoscopic examination usefulness, no vascular changes are observed in primary Raynaud's in contrast with sclerosis-related Raynaud. 5 Some patients get capillary loss and others, avascular areas or hemorrhages, with no pathogenic explanation so far.
Dermatologists can use this easy, not time consuming tool in patients with lupus, dermatomyositis, scleroderma and Raynaud's phenomenon, helping rheumatologists to detect early changes in nail fold capillaries, and selecting them for capillaroscopy, when necessary. Cutolo et al. propose a severity index based on nail bed capillaroscopy in three stages (early, active, and late). 1 Handheld dermoscopy is likely unable to evaluate these stages, but could split healthy nail beds from those with pathological changes, thus detecting many cases with minimal involvement that benefit from closer follow up. 
